Vikrant Shrotriya said Human Mixtard is not being discontinued in India and will be supplied in vial presentation ...

European governments are examining whether U.S. President Donald Trump can force them to pay more for prescription medicines, ...

For us, halfway through the 2020s, it’s Mounjaro vs Ozempic, the battle of the fat jabs. In the first ever head-to-head ...

It's likely that Trump was referring to Elon Musk in the quoted tweet. Musk has publicly admitted to using weight-loss drugs ...

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

Donald Trump recently made fun of his friend who takes Ozempic, adding that the weight-loss drug doesn’t seem to be working ...

Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...